Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia
Case Report
First Online:
- 178 Downloads
- 1 Citations
Abstract
Case We report a case of simultaneous methemoglobinemia and hemolytic anemia, probably related to the use of rasburicase, in a child starting treatment for acute lymphoblastic leukemia (ALL). In addition, the patient developed symptoms of pancreatitis. All complications resolved after 3 days of supportive therapy. Conclusion Although usually well tolerated in pediatrics, physicians prescribing rasburicase should be aware of these possible life-threatening adverse reactions.
Keywords
Clinical pharmacy Hemolytic anemia Methemoglobinemia Pancreatitis Pediatric hemato-oncology RasburicaseNotes
Conflicts of interest
The authors have no conflicts of interest.
References
- 1.Ueng S. Rasburicase (Elitek): a novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent). 2005;18(3):275–9.Google Scholar
- 2.Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol. 2001;19(3):697–704.PubMedGoogle Scholar
- 3.Cairo MS. Prevention and treatment of hyperuricemia in hematological malignancies. Clin Lymphoma. 2002; Suppl 1:S26–31.Google Scholar
- 4.de Bont JM, Pieters R. Management of hyperuricemia with rasburicase review. Nucleosides Nucleotides Nucleic Acids. 2004;23(8–9):1431–40.CrossRefPubMedGoogle Scholar
- 5.Browning LA, Kruse J. Hemolysis and methemoglobinemia secondary to rasburicase administration. Ann Pharmacother. 2005;39(11):1932–5.CrossRefPubMedGoogle Scholar
- 6.Maher JF, Rath CE, Schreiner GE. Hyperuricemia complicating leukemia: treatment with allopurinol and dialysis. Arch Intern Med. 1969;123(2):198–200.CrossRefPubMedGoogle Scholar
- 7.E-Compendium. Scientific Leaflet Fasturtec (in Flemish). Available from: http://www.ecompendium.be/. Accessed on 12 May 2010.
- 8.Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 2001;97(10):2998–3003.CrossRefPubMedGoogle Scholar
- 9.Kizer N, Martinez E, Powell M. Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma. 2006;47(12):2648–50.CrossRefPubMedGoogle Scholar
- 10.Identifying Adverse Drug Reactions. Available from http://qmweb.dads.state.tx.us/MedSim/Naranjo.htm. Accessed on 14 Apr 2010.
- 11.Borinstein SC, Xu M, Hawkins DS. Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Pediatr Blood Cancer. 2008;50(1):189.CrossRefPubMedGoogle Scholar
- 12.Bhat P, Sisler I, Collier AB 3rd. Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient. Pediatr Blood Cancer. 2008;51(4):568.CrossRefPubMedGoogle Scholar
- 13.Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9.CrossRefPubMedGoogle Scholar
Copyright information
© Springer Science+Business Media B.V. 2010